Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Bakuchiol wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Bakuchiol and Matrixyl have evidence — compare verdict strength side-by-side.
Topical cosmetic only. Bakuchiol is typically formulated around 0.5-1% in leave-on serums or creams and applied to clean skin once or twice daily. Unlike retinol it is not photolabile, so it can be used AM or PM, though daily sunscreen is still recommended. There is no oral, injectable, or systemic dose — it is not ingested. This library does not provide an ingestion protocol.
any
Leave-on topical serum or cream (0.5-1% purified bakuchiol)
Topical cosmetic only. Matrixyl (palmitoyl pentapeptide-4 / pal-KTTKS, or the Matrixyl 3000 blend of palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7) is used at very low concentrations in leave-on serums and creams — clinical benefit was shown at as little as 3 ppm pal-KTTKS, and consumer products commonly list 3-10% of the branded blend. Applied to the target area once or twice daily. There is no oral, injectable, or systemic dose — it is not ingested.
any
Leave-on topical cosmetic (serum or cream) containing palmitoyl pentapeptide-4 or the Matrixyl 3000 blend
Throughout
8-12 weeks
Throughout
Throughout
Throughout
8-12 weeks
Cell studies
Throughout
Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing.
Br J Dermatol (2019) · Rct · n=44
Randomized, double-blind, 12-week study: 44 patients applied bakuchiol 0.5% cream twice daily or retinol 0.5% cream daily
Bakuchiol: a retinol-like functional compound revealed by gene expression profiling and clinically proven to have anti-aging effects.
Int J Cosmet Sci (2014) · In vitro
Comparative gene-expression profiling in a full-thickness skin model showed great similarity between retinol's and bakuchiol's effects on the gene-expression profile
Trichloroacetic acid model to accurately capture the efficacy of treatments for postinflammatory hyperpigmentation.
Arch Dermatol Res (2020) · Open label · n=20
Prospective, non-randomized vehicle-controlled trial in 20 subjects (phototypes IV-VI) with a history of acne-induced post-inflammatory hyperpigmentation
Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin.
Int J Cosmet Sci (2005) · Rct
The strongest human evidence: a 12-week, double-blind, placebo-controlled, split-face, left-right randomized trial in 93 women aged 35-55 (Procter & Gamble)
Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow's Feet.
J Clin Aesthet Dermatol (2023) · Rct
Double-blind randomized trial in 21 Indonesian women applying palmitoyl pentapeptide-4 (PPP-4) cream, acetyl hexapeptide-3 cream, or placebo twice daily for 8 weeks
Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS).
Biomol Ther (Seoul) (2014) · In vitro
In-vitro stability and permeation study in hairless-mouse skin comparing KTTKS with its palmitoylated derivative pal-KTTKS (Matrixyl)
Bakuchiol has a higher evidence score (4/10 vs 3/10) and wins in 1 of 3 categories.
For reduce wrinkles & fine lines, Bakuchiol has a higher relevance score (65 vs 60).
No known interactions between Bakuchiol and Matrixyl have been documented in our database. However, always consult a healthcare provider before combining supplements.